Animal Models of Portal Hypertension

Overview

Journal World J Gastroenterol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2006 Nov 1

PMID 17075968

Citations 39

Authors

Juan-G Abraldes

Marcos Pasarin

Juan-Carlos Garcia-Pagan

Affiliations

Soon will be listed here.

Abstract

Animal models have allowed detailed study of hemodynamic alterations typical of portal hypertension and the molecular mechanisms involved in abnormalities in splanchnic and systemic circulation associated with this syndrome. Models of prehepatic portal hypertension can be used to study alterations in the splanchnic circulation and the pathophysiology of the hyperdynamic circulation. Models of cirrhosis allow study of the alterations in intrahepatic microcirculation that lead to increased resistance to portal flow. This review summarizes the currently available literature on animal models of portal hypertension and analyzes their relative utility. The criteria for choosing a particular model, depending on the specific objectives of the study, are also discussed.

Citing Articles

New insight on the acute CCl-induced hepatotoxicity model in rats.

Dos Anjos Melo D, Silva M, de Oliveira N, de Oliveira Neto J, de Souza Lino Junior R, Cruz A Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 39878816 DOI: 10.1007/s00210-025-03824-6.

Eplerenone, a mineralocorticoid receptor inhibitor, reduces cirrhosis associated changes of hepatocyte glucose and lipid metabolism.

Mohib M, Rabe S, Nolze A, Rooney M, Ain Q, Zipprich A Cell Commun Signal. 2024; 22(1):614.

PMID: 39707386 PMC: 11660827. DOI: 10.1186/s12964-024-01991-2.

Resveratrol treatment ameliorates hepatic damage via the TGF-β/SMAD signaling pathway in a phenobarbital/CCl-induced hepatic fibrosis model.

Aykac M, Balkan E, Gedi Kli S, Ozturk N Iran J Basic Med Sci. 2024; 27(9):1124-1133.

PMID: 39055873 PMC: 11266736. DOI: 10.22038/IJBMS.2024.75737.16398.

Noncirrhotic portal hypertension-Historical perspectives bring clarity to the entity and its management.

Philips C, Sarin S Clin Liver Dis (Hoboken). 2024; 23(1):e0232.

PMID: 38881719 PMC: 11177835. DOI: 10.1097/CLD.0000000000000232.

Resveratrol protects against Schistosoma mansoni-induced liver fibrosis by targeting the Sirt-1/NF-κB axis.

Mostafa D, Eissa M, Ghareeb D, Abdulmalek S, Hewedy W Inflammopharmacology. 2023; 32(1):763-775.

PMID: 38041753 PMC: 10907480. DOI: 10.1007/s10787-023-01382-y.

References

Zhang J, Pegoli Jr W, Clemens M . Endothelin-1 induces direct constriction of hepatic sinusoids. Am J Physiol. 1994; 266(4 Pt 1):G624-32. DOI: 10.1152/ajpgi.1994.266.4.G624. View

Panes J, Casadevall M, Fernandez M, Pique J, Bosch J, Casamitjana R . Gastric microcirculatory changes of portal-hypertensive rats can be attenuated by long-term estrogen-progestagen treatment. Hepatology. 1994; 20(5):1261-70. DOI: 10.1002/hep.1840200525. View

Groszmann R . Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences. Hepatology. 1994; 20(5):1359-63. View

Claria J, Jimenez W, Ros J, Rigol M, Angeli P, Arroyo V . Increased nitric oxide-dependent vasorelaxation in aortic rings of cirrhotic rats with ascites. Hepatology. 1994; 20(6):1615-21. DOI: 10.1002/hep.1840200635. View

Burns R, Wu Y, Sitzmann J . Role of cirrhosis in the hemodynamic response to hemorrhage in portal hypertension. Surgery. 1995; 117(5):488-93. DOI: 10.1016/s0039-6060(05)80246-6. View

Cahill P, Foster C, Redmond E, Gingalewski C, Wu Y, Sitzmann J . Enhanced nitric oxide synthase activity in portal hypertensive rabbits. Hepatology. 1995; 22(2):598-606. View

Ros J, Claria J, Jimenez W, Bosch-Marce M, Angeli P, Arroyo V . Role of nitric oxide and prostacyclin in the control of renal perfusion in experimental cirrhosis. Hepatology. 1995; 22(3):915-20. View

Beck P, Lee S . Vitamin K1 improves survival in bile-duct-ligated rats with cirrhosis. J Hepatol. 1995; 23(2):235. DOI: 10.1016/0168-8278(95)80345-9. View

Colombato L, Albillos A, Groszmann R . The role of central blood volume in the development of sodium retention in portal hypertensive rats. Gastroenterology. 1996; 110(1):193-8. DOI: 10.1053/gast.1996.v110.pm8536856. View

10.

Noda S, Masumi S, Moriyama M, Kannan Y, Ohta M, Sugano T . Population of hepatic macrophages and response of perfused liver to platelet-activating factor during production of thioacetamide-induced cirrhosis in rats. Hepatology. 1996; 24(2):412-8. DOI: 10.1053/jhep.1996.v24.pm0008690413. View

11.

Sogni P, Sabry S, Moreau R, Gadano A, Lebrec D, Dinh-Xuan A . Hyporeactivity of mesenteric resistance arteries in portal hypertensive rats. J Hepatol. 1996; 24(4):487-90. DOI: 10.1016/s0168-8278(96)80170-x. View

12.

Fallon M, Abrams G, McGrath J, Hou Z, Luo B . Common bile duct ligation in the rat: a model of intrapulmonary vasodilatation and hepatopulmonary syndrome. Am J Physiol. 1997; 272(4 Pt 1):G779-84. DOI: 10.1152/ajpgi.1997.272.4.G779. View

13.

Gupta T, Toruner M, Chung M, Groszmann R . Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats. Hepatology. 1998; 28(4):926-31. DOI: 10.1002/hep.510280405. View

14.

DeLeve L, McCuskey R, Wang X, Hu L, McCuskey M, EPSTEIN R . Characterization of a reproducible rat model of hepatic veno-occlusive disease. Hepatology. 1999; 29(6):1779-91. DOI: 10.1002/hep.510290615. View

15.

Graupera M, Garcia-Pagan J, Abraldes J, Peralta C, Bragulat M, Corominola H . Cyclooxygenase-derived products modulate the increased intrahepatic resistance of cirrhotic rat livers. Hepatology. 2002; 37(1):172-81. DOI: 10.1053/jhep.2003.50004. View

16.

Yokoyama Y, Xu H, Kresge N, Keller S, Sarmadi A, Baveja R . Role of thromboxane A2 in early BDL-induced portal hypertension. Am J Physiol Gastrointest Liver Physiol. 2002; 284(3):G453-60. DOI: 10.1152/ajpgi.00315.2002. View

17.

Loureiro-Silva M, Cadelina G, Groszmann R . Deficit in nitric oxide production in cirrhotic rat livers is located in the sinusoidal and postsinusoidal areas. Am J Physiol Gastrointest Liver Physiol. 2002; 284(4):G567-74. DOI: 10.1152/ajpgi.00452.2002. View

18.

Theodorakis N, Wang Y, Skill N, Metz M, Cahill P, Redmond E . The role of nitric oxide synthase isoforms in extrahepatic portal hypertension: studies in gene-knockout mice. Gastroenterology. 2003; 124(5):1500-8. DOI: 10.1016/s0016-5085(03)00280-4. View

19.

Vorobioff J, Bredfeldt J, Groszmann R . Increased blood flow through the portal system in cirrhotic rats. Gastroenterology. 1984; 87(5):1120-6. View

20.

Kamath P, TYCE G, Miller V, Edwards B, RORIE D . Endothelin-1 modulates intrahepatic resistance in a rat model of noncirrhotic portal hypertension. Hepatology. 1999; 30(2):401-7. DOI: 10.1002/hep.510300235. View